Survey of isoniazid preventive therapy in South Africa, 2011

被引:18
作者
Chehab, J. C. [1 ]
Vilakazi-Nhlapo, K. [2 ]
Vranken, P. [1 ]
Peters, A. [1 ]
Klausner, J. D. [1 ]
机构
[1] Ctr Dis Control & Prevent, Pretoria, South Africa
[2] Natl Dept Hlth, Pretoria, South Africa
关键词
tuberculosis; HIV; co-infection; integration; prevention; HIV-INFECTION; ANTIRETROVIRAL THERAPY; TUBERCULOSIS INCIDENCE; IMPLEMENTATION; PEOPLE; BARRIERS; CLINICS; TRIAL;
D O I
10.5588/ijtld.11.0722
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
SETTING: Public health facilities in South Africa. OBJECTIVE: To assess the implementation of isoniazid preventive treatment (IPT) in South Africa in 2011. DESIGN: Cross-sectional study of 50 randomly selected facilities in South Africa. Trained interviewers administered a standardised questionnaire at each facility on aspects of IPT policy, implementation and recording and reporting. We calculated and compared descriptive statistics by province and facility type. RESULTS: Of the 49 participating sites, 35 provided IPT (71%). IPT was not available in any Western Cape facility (0%), and it was available at a few Mpumalanga (40%) and Limpopo (20%) sites. In February 2011, 46% of eligible human immunodeficiency virus (HIV) infected patients at IPT-providing sites had been initiated on IPT. Implementation by facility type was 27% among community health centres. Of all facilities with integrated tuberculosis (TB) and HIV committees (TB-HIV), 85% offered IPT compared to 59% of those without TB-HIV committees (P = 0.12). Availability of the 2010 South African National IPT guidelines was statistically significantly associated with sites providing IPT (84% vs. 29%, P = 0.006). CONCLUSION: IPT implementation in South Africa began in February 2011. The availability of IPT guidelines was strongly associated with IPT uptake. More operational studies are needed to improve IPT implementation among HIV-infected patients in South Africa.
引用
收藏
页码:903 / 907
页数:5
相关论文
共 27 条
[1]
Aït-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927
[2]
[Anonymous], 2009, Progress Report'
[3]
[Anonymous], 2010, GUID INT TUB CAS FIN
[4]
Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme [J].
Charalambous, Salome ;
Grant, Alison D. ;
Innes, Craig ;
Hoffmann, Christopher J. ;
Dowdeswell, Rob ;
Pienaar, Jan ;
Fielding, Katherine L. ;
Churchyard, Gavin J. .
AIDS, 2010, 24 :S5-S13
[5]
Tuberculosis preventive therapy in the era of HIV infection: Overview and research priorities [J].
Churchyard, Gavin J. ;
Scano, Fabio ;
Grant, Alison D. ;
Chaisson, Richard E. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 :S52-S62
[6]
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV [J].
Date, Anand A. ;
Vitoria, Marco ;
Granich, Reuben ;
Banda, Mazuwa ;
Fox, Mayada Youssef ;
Gilks, Charlie .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2010, 88 (04) :253-259
[7]
Isoniazid preventive therapy in HIV infection [J].
Dodd, Lori Elizabeth ;
Wilkinson, Robert John .
LANCET, 2011, 377 (9777) :1548-1550
[8]
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study [J].
Durovni, Betina ;
Cavalcante, Solange C. ;
Saraceni, Valeria ;
Vellozo, Vitoria ;
Israel, Giselle ;
King, Bonnie S. ;
Cohn, Silvia ;
Efron, Anne ;
Pacheco, Antonio G. ;
Moulton, Lawrence H. ;
Chaisson, Richard E. ;
Golub, Jonathan E. .
AIDS, 2010, 24 :S49-S56
[9]
Isoniazid preventive therapy for HIV-infected people: evidence to support implementation [J].
Eldred, Lois J. ;
Churchyard, Gavin ;
Durovni, Betina ;
Godfrey-Faussett, Peter ;
Grant, Alison D. ;
Getahun, Haileyesus ;
Chaisson, Richard E. .
AIDS, 2010, 24 :S1-S3
[10]
Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions [J].
Getahun, Haileyesus ;
Granich, Reuben ;
Sculier, Delphine ;
Gunneberg, Christian ;
Blanc, Leopold ;
Nunn, Paul ;
Raviglione, Mario .
AIDS, 2010, 24 :S57-S65